Cytarabine Injection, Solution
Product Images NDC 71288-109

2 FDA label images from Meitheal Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 71288-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cyt04 0001 01

Cyt04 0001 01
Chemical structure of Cytarabine, depicted as a molecular diagram showing its base and sugar components with labeled atoms and bonds.*
FDA Label Image

Cyt04 0001 02

Cyt04 0001 02
Cytarabine Injection 2 grams per 20 mL (100 mg per mL) in a 20 mL single-dose vial. The label indicates the drug is for intravenous, intrathecal, and subcutaneous use only. It is sterile, nonpyrogenic, and preservative-free. Manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, made in China. The label cautions that Cytarabine is a cytotoxic agent and instructs not to refrigerate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.